Robin Strzeminski

Consistent record of driving revenue growth, expanding market share and building long-term strategic partnerships Award-winning, results-driven sales leader with extensive experience across institutional, retail, specialty pharmacy, and wholesale channels. Known for leading complex, high-value contract negotiations with senior procurement and executive stakeholders while consistently exceeding national revenue and portfolio expansion targets. Bring deep pharmaceutical market expertise and disciplined, data-driven approach to pricing, forecasting, and commercial analytics.

Trusted cross-functional partner recognized for aligning Legal, Finance, Pricing, Marketing, Operations, and Sales teams to deliver compliant, profitable agreements and successful product launches in highly competitive markets.

Senior National Account Director - Milla Pharmaceuticals - White Lake Bear, MN

(2024 - 2026)

Steered development and execution of new startup Generic organization in US market. Control headquarter management with National customers within wholesale, GPOs, specialty pharmacy, distributors, retail chains, private label, and IDN sectors

• Led national sales strategies, expanding market presence and increasing revenue streams across all classes of trade.
• Fostered strong relationships with key accounts by tailoring solutions to meet client needs, while collaborating cross-functionally to deliver impactful business results.
• Surpassed first-year revenue goals by 45% ($3.95M vs. $2.7M projected), driven by winning and scaling the company’s largest client to date as the primary award with the largest compounder.
• Drove expansion initiatives that increased 2026 revenue expectations to $7.2M+, executing two portfolio acquisitions and adding 17 NDCs to the active portfolio.
• Collaborated across internal functionals, including Demand Planning, Quality, Operations, Regulatory, and 3PL logistics, mitigating business continuity issues.

National Account Director - Granules Pharmaceuticals - Chantilly, VA

(2022 - 2024)

Guided national account management and commercial operations. Served as primary customer-facing leader while stabilizing revenue performance and rebuilding commercial infrastructure. Owned strategic relationships across all major classes of trade and partnered cross-functionally to ensure continuity of supply, customer confidence, and achievement of aggressive financial objectives while standing up scalable commercial processes.

• Stabilized customer relationships, preserved customer trust, and prevented material revenue loss during operational distress by assuming ownership of 90% of all external communications through 2 third-party logistics transitions.
• Surpassed annual revenue expectations by driving coordinated account strategies and proactive customer engagement, exceeding $135M FY2023 revenue target 15% despite supply chain disruption and organizational transition.
• Built foundational commercial operating processes and enabled visibility, accountability, and scalable commercial execution by leading creation of onboarding workflows, contract execution practices, CRM implementation, and performance reporting.
• Maintained uninterrupted business continuity, adopted hands-on, cross-functional approach, and partnered with Demand Planning, Quality, Operations, Regulatory, and Logistics teams, resolving critical issues impacting customer fulfillment and service levels.

National Account Director - ECI Pharma - Fort Lauderdale, FL

(2020 - 2022)

• Performed detailed business and account planning and analysis to assess profitability and desirability of potential customers before entering contractual relationships.
• Negotiated mutually beneficial corporate contracts for assigned national accounts, maximizing business opportunities and ensuring distribution, reimbursement, and profitability of product line.
• Identified and cultivated new business opportunities within highly competitive marketplace through extensive headquarter management with National customers within Wholesale, GPOs, Specialty Pharmacy, Distributors, Retail Chains, and Veterinarian channels.

Director, Institutional Sales & Contracts - Bausch Health, (EV ERSANA) - Bridgewater, NJ

(2019 - 2020)

Guided national team of 10 Integrated Account Managers charged with supporting multiple products within diversified portfolios. Developed strategic requirements for commercial distribution and related contract proposals for rare disease, specialty, and generic product portfolio Interaction with KOLs, executive level management for P&T, purchasing, and disease state protocol pathways.

• Defined measures of success for all Key Account Managers, including branches of distribution, IDN, Institutional, Specialty pharmacy, LTC, and military account sectors, enhancing team performance.
• Partnered with Legal, developing compliant, consistent, and timely contracts that supported business and sales objectives.

National Account Director - Asembia - Florham Park, NJ

(2016 - 2019)

• Managed and maintained $200M+ n generic net revenue sales focusing on Oncology / Hematology, Neurology, Transplant, HIV, Multiple Sclerosis, and numerous other specialty therapeutic classes.
• Assisted manufacturers on launches of specialty generic products, launching REMs programs, HUB services, and copay assistance.
• Negotiated “one off” Specialty pharmacy contracts with manufacturers, preventing price erosion and gaining market share visibility.

National Account Director - Pfizer, Greenstone LLC - Peapack, NJ

(2011 - 2016)

Managed National customers within Wholesale, GPOs, Specialty Pharmacy, Distributors, Retail Chains, Veterinarian, Mail Order and Clinical Trials, and Club Channels. Managed negotiations, distribution services, and strategic business agreements. Reviewed forecast quantities monitored account inventory, and distribution of products. Analyzed bid processes, ROFR analysis, and price change requests as well as customer targeting for market share initiatives.

• Generated $300M+ of new revenue streams in Generics year after year by identifying and cultivating new business opportunities within highly competitive marketplace.
• Selected to Vice President's Cabinet from 2011 to 2016 for outstanding performance and sales achievements.

Senior Category Director - AmerisourceBergen (Cencora) - Chesterbrook, PA

(2006 - 2011)

Owned manufacturer partnership strategy across Generic, OTC, and Private Label portfolios, directing contract governance, pricing strategy, and supplier engagement within complex regulatory and market conditions. Served as a cross-functional connector with senior leaders in Legal, Accounting, Purchasing, Inventory, and Pharmacy Operations to integrate supplier decisions with enterprise financial goals and nationwide pharmacy execution.

• Improved portfolio competitiveness by optimizing supplier mix and commercial terms across multiple product categories.
• Preserved product availability during market volatility through proactive risk management and supplier accountability.

Master of Business Administration (MBA) - St. Joseph’s University

Bachelor of Science (BS) - East Stroudsburg University